MicroRNA-146a promotes mycobacterial survival in macrophages through suppressing nitric oxide production

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Li, Miao ^a,b   Wang, Jinli ^a,b,c   Fang, Yimin ^d   Gong, Sitang ^a   Li, Meiyu ^a,b   Wu, Minhao ^a,b   Lai, Xiaomin ^b   Zeng, Gucheng ^b   Wang, Yi ^a,b   Yang, Kun ^a,b   Huang, Xi ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d GUANGZHOU CHEST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MICRORNA; MIRN146 MICRORNA, MOUSE; NITRIC OXIDE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL LINE; CONFOCAL MICROSCOPY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; MACROPHAGE; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; MYCOBACTERIUM BOVIS; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUBERCULOSIS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE, INBRED C57BL; MICROBIAL VIABILITY; MICRORNAS; MICROSCOPY, CONFOCAL; MYCOBACTERIUM BOVIS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TNF RECEPTOR-ASSOCIATED FACTOR 6; TUBERCULOSIS;

EID: 84963670098     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23351     Document Type: Article

References (54)

1. Lienhardt, C. et al. Global tuberculosis control: lessons learnt and future prospects. Nat. Rev. Microbiol. 10, 407-416 (2012).
2. Zumla, A. et al. The WHO 2014 global tuberculosis report-further to go. Lancet Glob. Health 3, e10-12 (2015).
3. Getahun, H., Matteelli, A., Chaisson, R. E., Raviglione, M. Latent Mycobacterium tuberculosis infection. N. Engl. J. Med. 372, 2127-2135 (2015).
4. Pieters, J. Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe 3, 399-407 (2008).
5. Flynn, J. L., Chan, J. Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93-129 (2001).
6. Berrington, W. R., Hawn, T. R. Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter? Immunol. Rev. 219, 167-186 (2007).
7. Bhatt, K., Salgame, P. Host innate immune response to Mycobacterium tuberculosis. J. Clin. Immunol. 27, 347-362 (2007).
8. Means, T. K. et al. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163, 3920-3927 (1999).
9. Abel, B. et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 169, 3155-3162 (2002).
10. Bafica, A. et al. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 202, 1715-1724 (2005).
11. Underhill, D. M., Ozinsky, A., Smith, K. D., Aderem, A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA. 96, 14459-14463 (1999).
12. Hacker, H. et al. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J. Exp. Med. 192, 595-600 (2000).
13. Gohda, J., Matsumura, T., Inoue, J. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling. J. Immunol. 173, 2913-2917 (2004).
14. Takeuchi, O., Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010).
15. Bogdan, C. Nitric oxide and the immune response. Nat. Immunol. 2, 907-916 (2001).
16. Bogdan, C. Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol. 36, 161-178 (2015).
17. Brightbill, H. D. et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285, 732-736 (1999).
18. Thoma-Uszynski, S. et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291, 1544-1547 (2001).
19. MacMicking, J. D. et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94, 5243-5248 (1997).
20. Nozaki, Y., Hasegawa, Y., Ichiyama, S., Nakashima, I., Shimokata, K. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect. Immun. 65, 3644-3647 (1997).
21. Kleinert, H., Schwarz, P. M., Forstermann, U. Regulation of the expression of inducible nitric oxide synthase. Biol. Chem. 384, 1343-1364 (2003).
22. He, L., Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531 (2004).
23. Filipowicz, W., Bhattacharyya, S. N., Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9, 102-114 (2008).
24. Taganov, K. D., Boldin, M. P., Baltimore, D. MicroRNAs and immunity: tiny players in a big field. Immunity 26, 133-137 (2007).
25. Wang, J. et al. MicroRNA-155 induction by Mycobacterium bovis BCG enhances ROS production through targeting SHIP1. Mol. Immunol. 62, 29-36 (2014).
26. Wang, J. et al. MicroRNA-155 promotes autophagy to eliminate intracellular mycobacteria by targeting Rheb. PLoS Pathog. 9, e1003697 (2013).
27. Ma, F. et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat. Immunol. 12, 861-869 (2011).
28. Liu, Y., Jiang, J., Wang, X., Zhai, F., Cheng, X. miR-582-5p is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO1. PLoS One 8, e78381 (2013).
29. Fremond, C. M. et al. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Invest. 114, 1790-1799 (2004).
30. Taganov, K. D., Boldin, M. P., Chang, K. J., Baltimore, D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103, 12481-12486 (2006).
31. Hou, J. et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183, 2150-2158 (2009).
32. Mehta, M. D., Liu, P. T. microRNAs in mycobacterial disease: friend or foe? Front. Genet. 5, 231 (2014).
33. Xiao, C., Rajewsky, K. MicroRNA control in the immune system: basic principles. Cell 136, 26-36 (2009).
34. Wu, S. et al. miR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6. J. Infect. 67, 329-341 (2013).
35. Ho, B. C. et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat. Commun. 5, 3344 (2014).
36. Schnitger, A. K. et al. Listeria monocytogenes infection in macrophages induces vacuolar-dependent host miRNA response. PLoS One 6, e27435 (2011).
37. Spinelli, S. V. et al. Altered microRNA expression levels in mononuclear cells of patients with pulmonary and pleural tuberculosis and their relation with components of the immune response. Mol. Immunol. 53, 265-269 (2013).
38. Liu, Z. et al. Analysis of miRNA expression profiling in human macrophages responding to Mycobacterium infection: induction of the immune regulator miR-146a. J. Infect. 68, 553-561 (2014).
39. Nahid, M. A., Pauley, K. M., Satoh, M., Chan, E. K. miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. J. Biol. Chem. 284, 34590-34599 (2009).
40. Jiang, M. et al. Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages. Aging Cell 11, 29-40 (2012).
41. Li, S., Yue, Y., Xu, W., Xiong, S. MicroRNA-146a represses mycobacteria-induced inflammatory response and facilitates bacterial replication via targeting IRAK-1 and TRAF-6. PLoS One 8, e81438 (2013).
42. Lu, L. F. et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142, 914-929 (2010).
43. Etzrodt, M. et al. Regulation of monocyte functional heterogeneity by miR-146a and Relb. Cell Rep. 1, 317-324 (2012).
44. Nahid, M. A., Satoh, M., Chan, E. K. Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J. Immunol. 186, 1723-1734 (2011).
45. Guo, Z. et al. miRNA-939 regulates human inducible nitric oxide synthase posttranscriptional gene expression in human hepatocytes. Proc. Natl. Acad. Sci. USA 109, 5826-5831 (2012).
46. Zhu, H. et al. NPM-ALK up-regulates iNOS expression through a STAT3/microRNA-26a-dependent mechanism. J. Pathol. 230, 82-94 (2013).
47. Wang, X. et al. Inducible nitric-oxide synthase expression is regulated by mitogen-activated protein kinase phosphatase-1. J. Biol. Chem. 284, 27123-27134 (2009).
48. Yang, K. et al. miR-155 suppresses bacterial clearance in Pseudomonas aeruginosa-induced keratitis by targeting Rheb. J. Infect. Dis. 210, 89-98 (2014).
49. Wang, J. et al. MRP8/14 induces autophagy to eliminate intracellular Mycobacterium bovis BCG. J. Infect. 70, 415-426 (2015).
50. Wu, M. et al. TREM-1 amplifies corneal inflammation after Pseudomonas aeruginosa infection by modulating Toll-like receptor signaling and Th1/Th2-type immune responses. Infect. Immun. 79, 2709-2716 (2011).
51. He, M., Xu, Z., Ding, T., Kuang, D. M., Zheng, L. MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta. Cell. Mol. Immunol. 6, 343-352 (2009).
52. Yang, K. et al. Functional RIG-I-like receptors control the survival of mesenchymal stem cells. Cell Death Dis. 4, e967 (2013).
53. Yang, K. et al. Mesenchymal stem cells detect and defend against gammaherpesvirus infection via the cGAS-STING pathway. Sci. Rep. 5, 7820 (2015).
54. Chen, K. et al. ?-Catenin promotes host resistance against Pseudomonas aeruginosa keratitis. J. Infect. 67, 584-594 (2013).